Antibodies are the immune system's precision tools for recognizing and neutralizing viruses, bacteria and other foreign ...

QureBio Ltd., a clinical-stage biotech company focusing on development of bispecific antibodies and other engineered Biopharmaceuticals for the treatment of cancer, inflammation, and other serious ...

Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a ...

Takeda (TSE:4502/NYSE:TAK) today announced the U.S. availability of GAMMAGARD LIQUID™ ERC [immune globulin infusion (human)] ...

A new OHSU study shows how the immune system can quietly disrupt brain function — and why the disease is often hard to ...

Cases of respiratory syncytial virus are increasing, but vaccines and antibody shots can keep young children out of the ...

Ouro Medicines, a clinical stage biotechnology company developing immune reset therapeutics for people living with chronic, ...

Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, which results in rigid, malformed red blood cells with a sickle shape. This ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Good afternoon, everybody. Thank you so much for joining us on day 3 of the J.P. Morgan Healthcare Conference. My name is Bhavana Balakrishnan, and I'm an associate from the health care investment ...

FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...